We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Biome Technologies Plc | AQSE:BIOM.GB | Aquis Stock Exchange | Ordinary Share | GB00B9Z1M820 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 105.00 | 90.00 | 120.00 | 105.00 | 105.00 | 105.00 | 0.00 | 06:56:49 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMBIOM
RNS Number : 4747I
Biome Technologies PLC
31 August 2016
31 August 2016
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").
Biome Technologies plc
("Biome", "the Company" or "the Group")
Interim Results
Biome Technologies plc announces its Interim Results for the six months ended 30 June 2016.
Highlights
-- Group revenues GBP2.2m (H1 2015: GBP2.1m)
-- Reduced loss before interest, depreciation, amortisation, and share option charges of GBP0.1m (H1 2015: loss of GBP0.3m)
-- Margins improved at 50% (H1 2015: 39%) -- Initial quantities of the "BiomeMesh" product delivered by the Bioplastics Division -- Healthy Stanelco RF Technologies enquiry book stretching into 2017
Paul Mines, Chief Executive Officer said:
"The prospects for the suite of bio-materials for the coffee market developed by the Biome Bioplastics division is encouraging as products move into commercialisation albeit exact timing of large scale deployment rests on extensive final testing. The RF Division continues to deliver a strong underlying performance."
For further information please contact:
Hot Features
Premium
Biome Technologies plc
Paul Mines, Chief Executive
Officer
Declan Brown, Group Finance
Director
www.biometechnologiesplc.com Tel: +44 (0) 2380 867
100
Allenby Capital
David Hart/Alex Brearley
(Nominated Adviser)
Chris Crawford/Kelly
Gardiner (Broker)
www.allenbycapital.com Tel: +44 (0) 20 3328
5656
FTI Consulting
Oliver Winters Tel: +44 (0) 20 3727
www.fticonsulting.com 1535
Chairman's Statement
The Group results for the first half of 2016 were ahead of those seen in the first half of 2015, with a strong first half for Stanelco RF Technologies more than offsetting a more subdued performance within the Biome Bioplastics division. The Group loss of GBP0.4m was ahead of the prior year with improved margins.
Group revenues were GBP2.2m compared to GBP2.1m in the first half of 2015. Gross profit of GBP1.1m was ahead of the first half of 2015 (GBP0.8m). Margins, at 50%, were ahead of the prior year figure of 39%, underpinned by an improvement in product mix.
The loss before interest, depreciation, amortisation and share option effects for the six months to 30 June 2016 was GBP0.1m compared to a loss of GBP0.3m in the first half of 2015. The loss after taxation was GBP0.4m (H1 2015: loss GBP0.6m) equating to a loss per share of 16 pence (H1 2015 loss per share 24 pence).
Net decrease in cash and cash equivalents in the period was GBP0.6m which included operating cash usage of GBP0.2m and GBP0.3m expenditure on research and development for new products within the Bioplastics division. In addition, there was a GBP0.1m increase in working capital ahead of equipment order shipments within the Stanelco RF Technologies division in the second half of 2016. The Group's cash position at 30 June 2016 was GBP1.0m.
Bioplastics Division
Revenues in the Bioplastics division for the first half of 2016 were GBP0.6m (H1 2015: GBP1.0m). This reduction in turnover was reflected in the operating loss for the period of GBP0.15m (2015: loss of GBP0.07m) although partially offset by improved margins. The subdued turnover in H1 results from the timing of end market campaign runs of the now commercialised packaging and lidding materials; this is a feature of this business and a firmer H2 is expected.
Biome has been developing a closely related suite of materials to enable coffee pod producers to sell biodegradable end products to the US consumer market. The materials Biome has been developing comprise first, the outer packaging and the lid; next, the ring of the pod; and lastly, the "non-woven" filter of the pod. Taken together these various biodegradable parts will enable the market to move to a fully compostable pod and each part has entailed significant development cost both in time and in production testing. The packaging and lid materials have completed their development stages and have been in full production since the middle of last year. The ring and filter materials are in the advanced stages of development.
In the trading statement of 27 June 2016, it was noted that whilst the second half of this year should be favourably impacted as the ring reaches its commercialisation phase, it had become clear that the inflexion point of significant revenue uplift would occur later in the half year than the Board had previously expected. As we now move through the second half of the year, Biome's customers continue to complete their own work to industrialise this innovative product and good progress is being made towards full commercialisation.
Encouragingly, in the last month, initial commercial quantities of the "mesh" product have now been supplied and whilst there is much work to do to ensure an efficient scale-up of production, it is anticipated that revenues will commence in the second half of 2016 but move into full commercialisation in 2017.
Over the last few years, the division has been awarded a number of grants to develop a new range of lignocellulose-derived bioplastics that can be made at comparable cost to traditional petro-chemicals. These development projects are at various stages of completion with one project completing its feasibility study in May 2016 with very encouraging results. Further updates on the progress of these projects will be made as they evolve.
Stanelco RF Technologies Division
Revenues in the RF Technologies division were GBP1.6m (H1 2015: GBP1.0m) reflecting a good order load in the first half. The division continued to make a positive contribution, with operating profit in the first half of GBP0.4m (H1 2015: GBP0.1m).
The contract announced in 2014 year to supply advanced analytical equipment to a UK regulated industry sector using the division's induction heating technology is nearing completion. The first of the two units was delivered in July 2016 with the second unit anticipated for delivery within the second half of 2016.
Revenues generated from the division's position in the fibre optic furnace market remain moderate albeit there are some signs in the enquiry level of increased appetite for investment in this sector.
Recently, the division has signed a contract to undertake the development of the technology and design behind an innovative pipe welder for a business in continental Europe. If this initial element of the project is successful, it is likely to lead to an important new revenue stream in 2018 and beyond.
General enquiry levels within the division remain encouraging with a healthy enquiry book stretching into 2017.
Outlook
The Board remains confident that the Group's existing and emerging portfolio of exciting products will give rise to a significant and valuable business stream. However, revenues for the remainder of 2016 and the early part of 2017 will reflect the unpredictability and volatility related to the Bioplastics product suite being in the early stages of commercialisation. The Board continues to expect Group revenues for the year to 31 December 2016 to be marginally ahead of those achieved in the prior year.
John Standen
Chairman
CONSOLIDATED STATEMENT
OF COMPREHENSIVE INCOME
For the period ended 30 June
2016
Total Total
for for
Total
6 Months 6 Months Year
Ended Ended ended
30 June 30 June 31 December
2016 2015 2015
Unaudited Unaudited Audited
Note GBP'000 GBP'000 GBP'000
------------------------------- ------ ---------- ---------- ------------
5a
REVENUE - 5c 2,162 2,056 4,882
Cost of sales (1,082) (1,247) (2,759)
GROSS PROFIT 1,080 809 2,123
Administrative expenses (1,453) (1,348) (2,904)
5a
LOSS FROM OPERATIONS - 5c (373) (539) (781)
Loss from operations before
exceptional items & share
options charges (311) (477) (656)
Share options charges (62) (62) (125)
Investment revenue 3 4 7
Foreign exchange gain/(loss) 1 (27) (18)
LOSS BEFORE TAXATION (369) (562) (792)
Taxation 6 - - 59
TOTAL COMPREHENSIVE INCOME
FOR THE PERIOD ATTRIBUTABLE
TO THE EQUITY HOLDERS OF THE
PARENT (369) (562) (733)
========== ========== ============
Basic and diluted loss per
share - pence 7 (16) (24) (31)
CONSOLIDATED STATEMENT
OF FINANCIAL POSITION
As at 30 June 2016
At At At
30 June 30 June 31 December
2016 2015 2015
Unaudited Unaudited Audited
Note GBP'000 GBP'000 GBP'000
------------------------------- ----- ---------- ---------- ------------
NON-CURRENT ASSETS
Other intangible assets 8 1,503 1,250 1,365
Property, plant and equipment 9 190 236 209
---------- ---------- ------------
1,693 1,486 1,574
---------- ---------- ------------
CURRENT ASSETS
Inventories 10 1,210 826 1,045
Trade and other receivables 11 1,413 857 1,334
Cash and cash equivalents 1,018 1,760 1,588
---------- ---------- ------------
3,641 3,443 3,967
---------- ---------- ------------
TOTAL ASSETS 5,334 4,929 5,541
========== ========== ============
CURRENT LIABILITIES
Trade and other payables 12 1,726 906 1,626
1,726 906 1,626
---------- ---------- ------------
TOTAL LIABILITIES 1,726 906 1,626
========== ========== ============
NET ASSETS 3,608 4,023 3,915
========== ========== ============
EQUITY
Share capital 117 117 117
Share premium account 740 740 740
Capital redemption reserve 4 4 4
Share options reserve 586 579 542
Translation reserve (85) (85) (85)
Retained profits/(losses) 2,246 2,668 2,597
EQUITY ATTRIBUTABLE TO
EQUITY HOLDERS OF THE PARENT
AND TOTAL EQUITY 3,608 4,023 3,915
========== ========== ============
The interim statements were approved by the Board on 30 August 2016.
Signed on behalf of the Board of Directors
Paul R Mines (Chief Executive)
Declan L Brown (Group Finance Director)
30 August 2016
CONSOLIDATED
STATEMENT OF
CHANGES IN EQUITY
As at 30 June 2016
Share Capital Share
Share premium redemption options Translation Retained TOTAL
capital account reserve reserve reserve earnings EQUITY
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Unaudited
Balance at 1
January 2016 117 740 4 542 (85) 2,597 3,915
========= ========= ============ ========= ============ ========== ========
Share options
issued in share
based payments - - - 62 - - 62
Cancellation
of time expired
share options - - - (18) - 18 -
--------- --------- ------------ --------- ------------ ---------- --------
Transactions
with owners - - - 44 - 18 62
--------- --------- ------------ --------- ------------ ---------- --------
Loss for the
period - - - - - (369) (369)
Total comprehensive
income for the
period - - - - - (369) (369)
--------- --------- ------------ --------- ------------ ---------- --------
Balance 30 June
2016 117 740 4 586 (85) 2,246 3,608
========= ========= ============ ========= ============ ========== ========
Unaudited
Balance at 1
January 2015 117 740 4 531 (85) 3,216 4,523
========= ========= ============ ========= ============ ========== ========
Share options
issued in share
based payments - - - 62 - - 62
Cancellation
of share scheme - - - (14) - 14 -
Transactions
with owners - - - 48 - 14 62
--------- --------- ------------ --------- ------------ ---------- --------
Loss for the
period - - - - - (562) (562)
Total comprehensive
income for the
period - - - - - (562) (562)
--------- --------- ------------ --------- ------------ ---------- --------
Balance 30 June
2015 117 740 4 579 (85) 2,668 4,023
========= ========= ============ ========= ============ ========== ========
Share Capital Share
Share premium redemption options Translation Retained TOTAL
capital account reserve reserve reserves earnings EQUITY
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Audited
Balance at 1
January 2015 117 740 4 531 (85) 3,216 4,523
========= ========= ============ ========= ============ ========== ========
Share options
issued in share
based payments - - - 125 - - 125
Cancellation
of share scheme - - - (114) - 114 -
Transactions
with owners - - - 11 - 114 125
--------- --------- ------------ --------- ------------ ---------- --------
Loss for the
year - - - - - (733) (733)
Total comprehensive
income for the
year - - - - - (733) (733)
--------- --------- ------------ --------- ------------ ---------- --------
Balance 31 December
2015 117 740 4 542 (85) 2,597 3,915
========= ========= ============ ========= ============ ========== ========
CONSOLIDATED STATEMENT
OF CASH FLOWS
For the period ended 30 June
2016
6 Months 6 Months Year
Ended Ended ended
30 June 30 June 31 December
2016 2015 2015
Unaudited Unaudited Audited
GBP'000 GBP'000 GBP'000
------------------------------------ ---------- ---------- ------------
Loss from operations (373) (539) (781)
Adjustment for:
Amortisation and impairment
of intangible assets 130 146 275
Depreciation of property,
plant and equipment 32 32 65
Share based payments 62 62 125
Foreign exchange 1 (21) (17)
---------- ---------- ------------
Operating cash flows before
movement of working capital (148) (320) (333)
(Increase)/Decrease in inventories (166) 180 (33)
(Increase)/decrease in receivables (78) 10 (468)
Increase/(decrease) in payables 100 (322) 397
---------- ---------- ------------
Cash utilised in operations (292) (452) (437)
Corporation tax (paid)/received - - 59
---------- ---------- ------------
Net cash outflow from operating
activities (292) (452) (378)
---------- ---------- ------------
Cash flows from investing
activities
Interest received 3 4 7
Investment in intangible
assets (269) (179) (423)
Purchase of property, plant
and equipment (12) (6) (11)
---------- ---------- ------------
Net cash used in investing
activities (278) (181) (427)
---------- ---------- ------------
Net decrease in cash and
cash equivalents (570) (633) (805)
Cash and cash equivalents
at beginning of period 1,588 2,393 2,393
---------- ---------- ------------
Cash and cash equivalents
at end of period 1,018 1,760 1,588
========== ========== ============
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
For the period ended 30 June 2016
1. CORPORATE INFORMATION
The financial information for the year ended 31 December 2015 set out in this interim report does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The Group's statutory financial statements for the year ended 31 December 2015 have been filed with the Registrar of Companies. The auditor's report on those financial statements was unqualified and did not contain statements under Section 498 of the Companies Act 2006. The interim results are unaudited. Biome Technologies plc is a public limited company incorporated and domiciled in England & Wales. The company's shares are publicly traded on the AIM market of the London Stock Exchange.
2. BASIS OF PREPARATION
These interim consolidated financial statements (the interim financial statements) are for the six months ended 30 June 2016. They have been prepared in accordance with IFRSs as adopted by the European Union and IAS 34 Interim Financial Reporting. They do not include all of the information required for full annual financial statements, and should be read in conjunction with the consolidated financial statements of the Group for the year ended 31 December 2015.
These interim financial statements have been prepared under the historical cost convention.
These interim financial statements have been prepared in accordance with the accounting policies adopted in the last annual financial statements for the year to 31 December 2015.
The accounting policies have been applied consistently throughout the Group for the purposes of preparation of the interim financial statements.
3. BASIS OF CONSOLIDATION
The Group interim financial statements consolidate the results of the Company and all of its subsidiary undertakings drawn up to 30 June 2016. At 30 June 2016 the subsidiary undertakings were Biome Bioplastics Limited, Stanelco RF Technologies Limited, Aquasol Limited and InGel Technologies Limited.
4. GOING CONCERN
The directors have reviewed forecasts and budgets for the coming 12 months, which have been drawn up with appropriate regard for the current macroeconomic environment and the particular circumstances in which the Group operates. As a result of this process, the directors are satisfied that the group have sufficient resources to continue in operational existence for at least one year from the date of approval of the interim report.
5a. SEGMENTAL INFORMATION FOR 6 MONTHSED 30 JUNE 2016
RF Central
Bioplastics Technologies Costs Total
6 Months 6 Months 6 Months 6 Months
Ended ended ended Ended
30 June 30 June 30 June 30 June
2016 2016 2016 2016
GBP'000 GBP'000 GBP'000 GBP'000
Unaudited
Revenue from external
customers 578 1,584 - 2,162
(LOSS)/PROFIT FROM
OPERATIONS (146) 367 (594) (373)
Investment revenue 3
Foreign exchange gain 1
LOSS ATTRIBUTABLE
TO EQUITY SHAREHOLDERS (369)
=========
TOTAL ASSETS 1,965 2,168 1,201 5,334
========================= ============ ============== ========= =========
5b. SEGMENTAL INFORMATION FOR 6 MONTHSED 30 JUNE 2015
RF Central
Bioplastics Technologies Costs Total
6 Months 6 Months 6 Months 6 Months
ended ended ended Ended
30 June 30 June 30 June 30 June
2015 2015 2015 2015
GBP'000 GBP'000 GBP'000 GBP'000
Unaudited
Revenue from external
customers 1,020 1,036 - 2,056
(LOSS)/PROFIT FROM
OPERATIONS (72) 94 (561) (539)
Investment revenue 4
Foreign exchange gain (27)
LOSS ATTRIBUTABLE
TO EQUITY SHAREHOLDERS (562)
=========
TOTAL ASSETS 2,029 964 1,936 4,929
========================= ============ ============== ========= =========
5c. SEGMENTAL INFORMATION FOR YEARED 31 DECEMBER 2015
RF Central
Bioplastics Technologies Costs Total
Year Year Year Year
ended ended ended ended
31 31 31
December December 31 December December
2015 2015 2015 2015
GBP'000 GBP'000 GBP'000 GBP'000
Audited
Revenue from external customers 1,871 3,011 - 4,882
(LOSS)/PROFIT FROM OPERATIONS (157) 608 (1,232) (781)
Investment revenue 7
Finance charges -
Foreign exchange gain (18)
LOSS BEFORE TAXATION FROM
OPERATIONS (792)
Taxation 59
LOSS ATTRIBUTABLE TO EQUITY
SHAREHOLDERS (733)
==========
TOTAL ASSETS 1,816 2,181 1,544 5,541
================================= ============ ============== ============ ==========
6. TAXATION
The Group's policy is to recognise tax credits resulting from tax R&D claims on a cash received basis. The claim in respect of the year ended 31 December 2015 has not yet been settled and there is therefore no tax credit recognised in the period under review.
7. EARNINGS PER SHARE
The calculation of earnings per share is based on the loss attributable to the equity holders of the parent for the six months of GBP369,000 (2015: loss of GBP562,000) and a weighted average of 2,347,536 (2015: 2,347,536) ordinary shares in issue.
Basic and diluted earnings per share are equal in the six months ended 30 June 2016 as all outstanding share options were out of the money for the purposes of the diluted earnings per share calculation.
8. OTHER INTANGIBLE ASSETS
Other intangible assets increased in the period as a result of the capitalisation of GBP269,000 of product development costs exceeding the amortisation charge for the period of GBP130,000.
9. PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment decreased in the reporting period as a result of the purchase of property, plant and equipment of GBP12,000 being less than the depreciation charge for the period of GBP32,000.
10. INVENTORIES
The increase in inventories during the reporting period reflects the increase in equipment orders under construction within the Stanelco RF division. These orders are all due for shipment to the customers in the second half of the year.
11. TRADE AND OTHER RECEIVABLES
Trade and other receivables have increased during in the reporting period mainly due to the increases in accrued revenue on the equipment orders under construction within Stanelco RF mentioned above.
12. TRADE AND OTHER PAYABLES
The increase in trade and other payables during the reporting period primarily reflects the accrued cost of sales on the above mentioned accrued revenue on the equipment orders under construction within the Stanelco RF division.
13. RISKS AND UNCERTAINTIES
The principal risks and uncertainties affecting the business activities of the Group are detailed in the Strategic Report which can be found on pages 8-13 of the Annual Report and Financial Statements for the year ended 31 December 2015 ("the Annual Report"). A copy of the Annual Report and
Financial Statements is available on the Company's website at www.biometechnologiesplc.com
The risks affecting the business remain the same as in the Annual Report. In summary, these risks
include:
-- changes in the regulatory environments in which the Group operates -- fluctuations in exchange rates -- volatility in raw material prices and supply -- breach of intellectual property rights -- competitors developing more attractive products -- failure to commercialise products -- reliance on a small number of customers for certain products
-- financial risks including exchange rate risk, liquidity risk, interest rate risk and credit risk.
Further details of how these risks impact the business and how the directors attempt to mitigate
the risks can be found in the Annual Report.
INDEPENDENT REVIEW REPORT FOR BIOME TECHNOLOGIES PLC
Introduction
We have been engaged by the company to review the condensed set of financial statements in the half-yearly financial report of Biome Technologies Plc for the six months ended 30 June 2016 which comprises the consolidated statement of comprehensive income, consolidated statement of financial position, consolidated statement of changes in equity, consolidated statement of cash flows and the related notes. We have read the other information contained in the half yearly financial report which comprises only the Chairman's Statement and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.
This report is made solely to the company, in accordance with International Standard on Review Engagements (UK and Ireland) 2410, 'Review of Interim Financial Information performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board. Our review work has been undertaken so that we might state to the company those matters we are required to state to it in an independent review report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company for our review work, for this report, or for the conclusion we have formed.
Directors' responsibilities
The half-yearly financial report is the responsibility of, and has been approved by, the directors. As disclosed in note 2, the annual financial statements of the group are prepared in accordance with International Financial Reporting Standards as adopted by the European Union. The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with International Accounting Standard 34, 'Interim Financial Reporting', as adopted by the European Union.
Our responsibility
Our responsibility is to express a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review.
Scope of review
We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity'. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Conclusion
Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2016 is not prepared, in all material respects, in accordance with International Accounting Standard 34, 'Interim Financial Reporting', as adopted by the European Union.
GRANT THORNTON UK LLP
REGISTERED AUDITORS
CHARTERED ACCOUNTANTS
SOUTHAMPTON
30 August 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
IR LLFFDTLIIVIR
(END) Dow Jones Newswires
August 31, 2016 02:00 ET (06:00 GMT)
1 Year Biome Technologies Chart |
1 Month Biome Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
